<DOC>
	<DOCNO>NCT02107313</DOCNO>
	<brief_summary>This study design determine pharmacokinetic ( PK ) profile single oral dose PBT2 administer healthy volunteer presence absence food .</brief_summary>
	<brief_title>Phase 1 Study Determine Effects Food Pharmacokinetic Profile PBT2</brief_title>
	<detailed_description>The study conduct 2 dose period , participant randomise receive PBT2 250 mg without food first dosing period , follow 7 day washout period receive opposite fed/fasted condition allocate first dosing period . Pharmacokinetic sample collect dosing period , along safety monitoring assessment .</detailed_description>
	<criteria>Healthy male female BMI 19 30kg/m2 No clinically significant abnormality Exposure medications/drugs interfere metabolism PBT2 include drug inhibit induce CYP1A2 ) Use caffeinecontaining beverage , supplement alcohol within 72 hour study entry Significant history depression psychiatric illness Surgical medical condition could significantly alter drug absorption , distribution , metabolism excretion unable swallow capsule</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>